{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T11:17:27Z","timestamp":1774955847809,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.metabol.2005.11.003","type":"journal-article","created":{"date-parts":[[2006,3,18]],"date-time":"2006-03-18T07:36:31Z","timestamp":1142667391000},"page":"508-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents"],"prefix":"10.1016","volume":"55","author":[{"given":"Charles J.","family":"Glueck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa Aronson","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naila","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davis M.","family":"Stroop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2005.11.003_bib1","first-page":"3078","article-title":"Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study","volume":"83","author":"Knochenhauer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humrep\/deg056","article-title":"Low-dose combination of flutamide, metformin and an oral contraceptive for non-obese, young women with polycystic ovary syndrome","volume":"18","author":"Ibanez","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2005.11.003_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpeds.2003.08.015","article-title":"Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome","volume":"144","author":"Ibanez","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/j.metabol.2005.11.003_bib4","doi-asserted-by":"crossref","first-page":"5702","DOI":"10.1210\/jc.2002-020926","article-title":"Anovulation in eumenorrheic, nonobese adolescent girls born small for gestational age: insulin sensitization induces ovulation, increases lean body mass, and reduces abdominal fat excess, dyslipidemia, and subclinical hyperandrogenism","volume":"87","author":"Ibanez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib5","doi-asserted-by":"crossref","first-page":"3595","DOI":"10.1210\/jcem.86.8.7756","article-title":"Sensitization to insulin induces ovulation in nonobese adolescents with anovulatory hyperandrogenism","volume":"86","author":"Ibanez","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib6","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1046\/j.1365-2265.2001.01399.x","article-title":"Polycystic ovary syndrome after precocious pubarche: ontogeny of the low-birthweight effect","volume":"55","author":"Ibanez","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.metabol.2005.11.003_bib7","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/sj.ijo.0801994","article-title":"Obesity and the polycystic ovary syndrome","volume":"26","author":"Gambineri","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2005.11.003_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejogrb.2005.03.010","article-title":"Obesity and extreme obesity, manifest by ages 20-24 years, continuing through 32-41 years in women, should alert physicians to the diagnostic likelihood of polycystic ovary syndrome as a reversible underlying endocrinopathy","volume":"122","author":"Glueck","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.metabol.2005.11.003_bib9","series-title":"Polycystic ovary syndrome","first-page":"377","article-title":"Diagnostic criteria for polycystic ovary syndrome: a rational approach","author":"Kawadzki","year":"1992"},{"key":"10.1016\/j.metabol.2005.11.003_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2005.11.003_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0026-0495(97)90066-4","article-title":"Metformin therapy is associated with a decrease in plasma plasminogen activator inhibitor\u20131, lipoprotein(a), and immunoreactive insulin levels in patients with the polycystic ovary syndrome","volume":"46","author":"Velazquez","year":"1997","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2005.11.003_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0015-0282(99)00184-3","article-title":"Insulin, androgens, and obesity in women with and without polycystic ovary syndrome: a heterogeneous group of disorders","volume":"72","author":"Acien","year":"1999","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2005.11.003_bib13","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0026-0495(99)90113-0","article-title":"Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2005.11.003_bib14","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S1054-139X(01)00202-6","article-title":"Metformin to restore normal menses in oligo-amenorrheic teenage girls with polycystic ovary syndrome (PCOS)","volume":"29","author":"Glueck","year":"2001","journal-title":"J Adolesc Health"},{"key":"10.1016\/j.metabol.2005.11.003_bib15","doi-asserted-by":"crossref","first-page":"2858","DOI":"10.1093\/humrep\/17.11.2858","article-title":"Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin","volume":"17","author":"Glueck","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2005.11.003_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/S0015-0282(01)03202-2","article-title":"Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome","volume":"77","author":"Glueck","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/j.metabol.2005.11.003_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2265.2004.01973.x","article-title":"Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome","volume":"60","author":"Gambineri","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"Suppl 5","key":"10.1016\/j.metabol.2005.11.003_bib18","first-page":"1367","article-title":"Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome","volume":"15","author":"Legro","year":"2002","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib19","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Rotterdam ESHRE\/ASRM\u2013sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2005.11.003_bib21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2003-43304","article-title":"Diagnostic criteria in polycystic ovary syndrome","volume":"21","author":"Legro","year":"2003","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.metabol.2005.11.003_bib22","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/humrep\/deh263","article-title":"Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.metabol.2005.11.003_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11892-003-0022-0","article-title":"Metformin and gestational diabetes","volume":"3","author":"Glueck","year":"2003","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.metabol.2005.11.003_bib24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2002-020815","article-title":"Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome","volume":"88","author":"Moran","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11892-004-0014-8","article-title":"Treatment of PCOS with metformin and other insulin-sensitizing agents","volume":"4","author":"Seli","year":"2004","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.metabol.2005.11.003_bib26","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1067\/mpd.2001.109603","article-title":"Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome","volume":"138","author":"Lewy","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/j.metabol.2005.11.003_bib27","article-title":"Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first trimester miscarriage in women with polycystic ovary syndrome","author":"Glueck","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.metabol.2005.11.003_bib28","doi-asserted-by":"crossref","first-page":"5454","DOI":"10.1210\/jc.2003-032237","article-title":"Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome","volume":"89","author":"Talbott","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib29","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","article-title":"Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents","volume":"88","author":"Silfen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"Suppl 5","key":"10.1016\/j.metabol.2005.11.003_bib30","first-page":"1353","article-title":"Cardiovascular risk in adolescent and young adult obese females with polycystic ovary syndrome (PCOS)","volume":"14","author":"Macut","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.metabol.2005.11.003_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1542\/peds.2004-2358","article-title":"Development of the metabolic syndrome in black and white adolescent girls: a longitudinal assessment","volume":"116","author":"Morrison","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/j.metabol.2005.11.003_bib32","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","article-title":"New approach to polycystic ovary syndrome and other forms of anovulatory infertility","volume":"57","author":"Laven","year":"2002","journal-title":"Obstet Gynecol Surv"},{"key":"10.1016\/j.metabol.2005.11.003_bib33","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2005.11.003_bib34","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2105\/AJPH.82.12.1613","article-title":"Obesity and cardiovascular disease risk factors in black and white girls: the NHLBI Growth and Health Study","volume":"82","year":"1992","journal-title":"Am J Public Health"},{"key":"10.1016\/j.metabol.2005.11.003_bib35","unstructured":"2000 CDC growth charts: United States. National Center for Health Statistics, National Health and Nutrition Examination Survey. http:\/\/www.cdc.gov\/growthcharts\/."},{"key":"10.1016\/j.metabol.2005.11.003_bib36","unstructured":"SAS\/STAT software: changes and enhancements through release 9.1 SAS Institute, SAS Campus Drive, 2004."},{"key":"10.1016\/j.metabol.2005.11.003_bib37","article-title":"The Lipid Research Clinics population studies data book","volume":"vol. 1","year":"1980"},{"key":"10.1016\/j.metabol.2005.11.003_bib38","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1001\/jama.290.17.2271","article-title":"Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study","volume":"290","author":"Li","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2005.11.003_bib39","doi-asserted-by":"crossref","first-page":"E55","DOI":"10.1542\/peds.107.4.e55","article-title":"The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes","volume":"107","author":"Freemark","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.metabol.2005.11.003_bib40","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.2337\/diabetes.53.8.2087","article-title":"Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment Panel III criteria for the metabolic syndrome","volume":"53","author":"Carr","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2005.11.003_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/aje\/kwh250","article-title":"Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study","volume":"160","author":"Golden","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2005.11.003_bib42","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study","volume":"290","author":"Raitakari","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2005.11.003_bib43","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1038\/sj.ijo.0802404","article-title":"Change in body mass index from adolescence to young adulthood and increased carotid intima-media thickness at 28 years of age: the Atherosclerosis Risk in Young Adults study","volume":"27","author":"Oren","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2005.11.003_bib44","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1517\/14656566.3.8.1177","article-title":"Treatment of polycystic ovary syndrome with insulin-lowering agents","volume":"3","author":"Glueck","year":"2002","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.metabol.2005.11.003_bib45","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.2337\/diabetes.51.9.2796","article-title":"Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk Hispanic women","volume":"51","author":"Buchanan","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2005.11.003_bib46","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.metabol.2005.11.003_bib47","first-page":"737","article-title":"Type 2 diabetes mellitus in children and youth: a new epidemic","volume":"15","author":"Kaufman","year":"2002","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049505004361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049505004361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:05:13Z","timestamp":1758423913000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049505004361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S0026049505004361"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2005.11.003","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2005.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}